NEW YORK, Feb. 1, 2024 /PRNewswire/ -- Attention Assertio Holdings, Inc. ("Assertio Holdings") (NASDAQ: ASRT) shareholders:
The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between March 29, 2023 and November 8, 2023.
If you suffered a loss on your investment in Assertio Holdings, contact us about potential recovery by using the link below. There is no cost or obligation to you.
https://www.wongesq.com/pslra-1/assertio-holdings-class-action-submission-form/?prid=65378&wire=4
ABOUT THE ACTION: The class action against Assertio Holdings includes allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's reliance on Indocin products to boost its net income was unsustainable given the risk of generic competition; (ii) Assertio's acquisition of Spectrum Pharmaceuticals, Inc. and Spectrum's injection asset, Rolvedon, was less valuable than Assertio had represented to investors; (iii) accordingly, Assertio had overstated the positive impact the sale of Indocin products and the acquisition were likely to have on the Company's profitability; and (iv) as a result, defendants' public statements were materially false and/or misleading at all relevant times.
DEADLINE: March 5, 2024
Aggrieved Assertio Holdings investors only have until March 5, 2024 to request that the Court appoint you as lead plaintiff. You are not required to act as a lead plaintiff in order to share in any recovery.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
E-Mail: [email protected]
SOURCE The Law Offices of Vincent Wong
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article